Prot #214221: NEPTUNE-17/ A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate Efficacy, Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Adult Participants with Chronic Diabetic Peripheral NP

Project: Research project

Project Details

StatusActive
Effective start/end date12/4/23 → 12/4/26

Funding

  • PPD Investigator Services, LLC (Prot # 214221 // Prot # 214221)
  • GlaxoSmithKline LLC (Prot # 214221 // Prot # 214221)